Back to Stakeholders
Independent Academic Research GroupsSpecialized Academic Departments and Institutes

Karolinska Institutet

Sweden
2 Trials

Karolinska Institutet is Sweden's largest medical university and a leading European hub for psychedelic research, with the Centre for Psychiatry Research led by Prof. Johan Lundberg conducting PSIPET — Sweden's first RCT of psilocybin for major depressive disorder. The institute participates in the Nordic Network for Psychedelic Science and launched a doctoral course in psychedelic science in 2025.

Quick Facts

Type
Other
HQ
Sweden
Website
Visit

Collaborated Trials

2
RecruitingII

Cancer Related Major Depression Treated With a Single Dose of Psilocybin (CAPSI)

Start Date
Compounds
Psilocybin
CompletedII

The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density

Start Date
Compounds
Psilocybin, Placebo